HANCOCK WHITNEY CORP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$325,523
+18.4%
11,948
-3.5%
0.01%
+18.2%
Q2 2023$275,000
-27.2%
12,380
-29.1%
0.01%
-26.7%
Q1 2023$378,000
-7.1%
17,472
-12.8%
0.02%
-6.2%
Q4 2022$407,000
-21.1%
20,036
-0.4%
0.02%
-27.3%
Q3 2022$516,000
+5.5%
20,111
-2.3%
0.02%
+10.0%
Q2 2022$489,000
+1.7%
20,578
-3.7%
0.02%
+25.0%
Q1 2022$481,000
-5.7%
21,367
-17.0%
0.02%0.0%
Q4 2021$510,0000.0%25,733
-0.8%
0.02%
-11.1%
Q3 2021$510,000
-11.0%
25,936
-0.4%
0.02%0.0%
Q2 2021$573,000
-28.6%
26,029
-23.0%
0.02%
-33.3%
Q1 2021$803,000
-10.5%
33,784
-1.4%
0.03%
-10.0%
Q4 2020$897,000
+49.7%
34,268
-0.6%
0.03%
+36.4%
Q3 2020$599,000
+2.7%
34,465
-0.5%
0.02%0.0%
Q2 2020$583,000
+26.2%
34,636
-10.9%
0.02%
+22.2%
Q1 2020$462,000
+37.5%
38,877
+40.0%
0.02%
+63.6%
Q4 2019$336,000
-44.1%
27,760
-34.7%
0.01%
-45.0%
Q3 2019$601,000
+11.3%
42,520
-12.2%
0.02%
+17.6%
Q2 2019$540,00048,4220.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders